0000932352-18-000001.txt : 20180207 0000932352-18-000001.hdr.sgml : 20180207 20180207103102 ACCESSION NUMBER: 0000932352-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180207 DATE AS OF CHANGE: 20180207 EFFECTIVENESS DATE: 20180207 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Urigen Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0000932352 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943156660 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-304992 FILM NUMBER: 18579668 BUSINESS ADDRESS: STREET 1: 675 HIGHWAY ONE, SUITE B-206 CITY: NORTH BRUNSWICK STATE: NJ ZIP: 08902 BUSINESS PHONE: 732-640-0160 MAIL ADDRESS: STREET 1: 675 HIGHWAY ONE, SUITE B-206 CITY: NORTH BRUNSWICK STATE: NJ ZIP: 08902 FORMER COMPANY: FORMER CONFORMED NAME: VALENTIS INC DATE OF NAME CHANGE: 19990506 FORMER COMPANY: FORMER CONFORMED NAME: MEGABIOS CORP DATE OF NAME CHANGE: 19960716 D 1 primary_doc.xml X0708 D LIVE 0000932352 Urigen Pharmaceuticals, Inc. 675 HIGHWAY ONE, SUITE B-206 NORTH BRUNSWICK NJ NEW JERSEY 08902 732-640-0160 DELAWARE VALENTIS INC MEGABIOS CORP Corporation true Dan Vickery c/o Urigen Pharmaceuticals, Inc. 675 Highway One, Suite B-206 North Brunswick NJ NEW JERSEY 08902 Executive Officer Director C. Lowell Parsons c/o Urigen Pharmaceuticals, Inc. 675 Highway One, Suite B-206 North Brunswick NJ NEW JERSEY 08902 Director Abe Hahn c/o Urigen Pharmaceuticals, Inc. 675 Highway One, Suite B-206 North Brunswick NJ NEW JERSEY 08902 Director Carlo Di Fonzo c/o Urigen Pharmaceuticals, Inc. 675 Highway One, Suite B-206 North Brunswick NJ NEW JERSEY 08902 Director Pharmaceuticals Decline to Disclose 06b false 2018-01-26 false true false 13500 None None None None None None XX Unknown 99999 CA CALIFORNIA CO COLORADO FL FLORIDA GA GEORGIA NV NEVADA NJ NEW JERSEY NC NORTH CAROLINA PR PUERTO RICO SC SOUTH CAROLINA TX TEXAS false 1377000 1377000 0 Includes the conversion of $675,000 principal amount of convertible promissory notes previously issued by the issuer. false 22 0 0 0 false Urigen Pharmaceuticals, Inc. /s/ Dan Vickery Dan Vickery, M.B.A., Ph.D. President 2018-02-07